BlueCrest Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-1,593
Closed -$237K – 666
2019
Q2
$237K Sell
1,593
-28,291
-95% -$3.78M 0.02% 329
2019
Q1
$3.83M Buy
+29,884
New +$3.52M 0.15% 104
2018
Q4
– Sell
-9,605
Closed -$1.1M – 1377
2018
Q3
$1.1M Sell
9,605
-78
-0.8% -$8.82K 0.03% 412
2018
Q2
$1.02M Buy
9,683
+6,264
+183% +$630K 0.03% 522
2018
Q1
$319K Buy
3,419
+337
+11% +$30.6K 0.01% 1012
2017
Q4
$270K Buy
+3,082
New +$275K 0.01% 646
2017
Q2
– Sell
-34,998
Closed -$2.43M – 1087
2017
Q1
$2.43M Buy
+34,998
New +$2.42M 0.12% 212
2016
Q3
– Sell
-64,000
Closed -$4.4M – 977
2016
Q2
$4.4M Buy
+64,000
New +$4.48M 0.18% 129

Other funds holding STE

BlueCrest Capital Management's STE Position: Q3 2019 in Review

BlueCrest Capital Management sold out of Steris (STE) in Q3 2019, closing a stake of 1,593 shares — an estimated $237K sold.

BlueCrest Capital Management first reported a position in STE in Q2 2016 and held it in 8 quarters. The position peaked at $4.4M in Q2 2016. 480 funds tracked by Wall St. Rank hold STE as of Q3 2019.

  • BlueCrest Capital Management reported no remaining Steris position as of Q3 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 1,593 Steris shares in Q3 2019, an estimated $237K.
  • BlueCrest Capital Management first reported a position in Steris in Q2 2016 and held it in 8 quarters.
  • BlueCrest Capital Management's Steris position peaked at $4.4M in Q2 2016.
  • 480 funds tracked by Wall St. Rank held Steris as of Q3 2019.

Based on BlueCrest Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.